Company Profile
Spruce Biosciences Stock Price, News & Analysis
- Ticker:
- SPRB
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
46.42 USD (-0.41%)
Close
Last updated: August 6, 2026
136M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, SPRB closed down 0.41% at $46.42. No new same-company headline was identified in the current news window.
Company overview
Business overview
Spruce Biosciences is an endocrine and rare-disease company focused on hormonal and metabolic disorders. Its programs aim at difficult endocrine conditions with limited treatment options.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Spruce sits in specialty biotechnology.
Business Model Characteristics
The company depends on clinical data, regulatory steps, and the ability to build a focused rare-disease franchise.
Position Within the Biotechnology Landscape
Spruce is a small-cap catalyst name whose stock depends on proof-of-concept and development milestones.
Future catalysts
Spruce Biosciences’s catalysts are tildacerfont and the adrenal-disorder program, where any data or regulatory update can still move the story. The company needs a clearer clinical step to keep the platform credible.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Spruce Biosciences (SPRB)?
Spruce Biosciences (SPRB) most recently closed at 46.42 USD, a -0.41% move versus the previous session.
What is the market cap of Spruce Biosciences (SPRB)?
Spruce Biosciences currently has a market capitalization of 136M USD on BioPharmSignal.
What does Spruce Biosciences do?
Spruce Biosciences is an endocrine and rare-disease company focused on hormonal and metabolic disorders. Its programs aim at difficult endocrine conditions with limited treatment options.
On which exchange is SPRB stock listed?
Spruce Biosciences (SPRB) is associated with NASDAQ, United States, Biopharma.
What is Spruce?
Spruce Biosciences’s catalysts are tildacerfont and the adrenal-disorder program, where any data or regulatory update can still move the story.
Which conditions is Spruce Biosciences targeting with Spruce?
Spruce Biosciences is associated with metabolic disease based on its company overview and current catalyst commentary.
How does Spruce Biosciences describe recent progress with Spruce?
Spruce Biosciences’s catalysts are tildacerfont and the adrenal-disorder program, where any data or regulatory update can still move the story.
What is Biosciences?
Spruce Biosciences is an endocrine and rare-disease company focused on hormonal and metabolic disorders.